Loading...

FBLG FIBROBIOLOGICS INC Management Changes 8-K Filing

FBRB

FBLG

FIBROBIOLOGICS INC

(FBLG)

2026 8-K

Stock Offering Update

Stock Option Grant

ATM Offering Agreement

Compliance Confirmed

Bylaw Amendment

Sublease Termination

Lease Termination

Stock Split Announcement

Public Offering Details

CFO Salary Update

Special Meeting Results

Delisting Notice

Delisting Notice

Stock Offering Details

Securities Offering

Share Offering Announcement

Equity Offerings

Debt-Equity Swaps

Delisting due to Non-Compli...

Convertible Promissory Notes

Management Changes

Equity Financing

Executive Compensation

Equity Purchase Agreement

Equity Purchase Agreement

Service Agreement

Corporate Amendments

External Links:

On May 4, 2026, FibroBiologics, Inc. granted stock options for 92,410 shares to CEO Pete O’Heeron and 61,607 shares each to other executives at an exercise price of $1.38 per share, with a vesting schedule over four years.

AI Assistant

FIBROBIOLOGICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.